Co-Founder, President & CEO, General Counsel, and Director
United States of America
David Mallery is a Co-Founder, President and CEO of Paradigm. Mr. Mallery was also the Co-founder, President and a Director of the Molecular Profiling Institute and its subsidiary the Tissue Banking and Analysis Center (a joint venture with US Oncology/McKesson). Mr. Mallery helped lead this company through all of the financings and commercial transactions and ultimately through a successful merger. He subsequently served for a while in leadership at Caris Life Sciences (the acquiring company). Along with Dr. Daniel Von Hoff and his father, when his mother was diagnosed with aggressive cancer, Mr. Mallery helped co-found the International Genomics Consortium (IGC). He has served as President and Director of IGC and helped lead efforts to land and expand IGC’s role as the founding Biospecimen Core Resource and Tissue Source Site network for the National Cancer Institute’s flagship project – The Cancer Genome Atlas (TCGA). He was formerly the Principal Venture Analyst for the Calvert Group’s venture and equity fund investments and has been an investment advisor on numerous biotech investments through exit. Mr. Mallery is an active member of YPO, a life member of the Council on Foreign Relations and a member of the Colorado Bar Association and the District of Columbia Bar Association. Mr. Mallery has a JD and MBA from the University of Colorado at Boulder and a BA from Stanford University in Art Studio: Design and Human Biology.
Genetics, clinical trials, cancer